Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Premium intraocular lenses drive Q3 top-line for ophthalmic companies

This article was originally published in Clinica

Executive Summary

Advanced Medical Optics (AMO) continued to reap the rewards of its $1.3bn acquisition of refractive surgical company VISX (completed in May this year), with the latter contributing $47.7m to total third-quarter ophthalmic surgical revenues. Sales of laser vision correction (LVC) systems during this period were particularly robust, soaring 71% to $11.1m, compared with VISX's reported system sales in the third quarter last year, and revenues from LVC licensing fees rose 15% to $31.2m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel